Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE000A11QVV0
Thu, 25.09.2025
Heidelberg Pharma AG
Ad hoc announcement
Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014
Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment
Milestone payment of USD 70 million from royalty financing agreement with HealthCare Royalty delayed as payment co [ … ]
Thu, 28.08.2025
Heidelberg Pharma AG
Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
FDA has requested additional data relating to the Chemistry, Manufacturing, and Controls (CMC) package
Expected payment of USD 70 million from HealthCare Royalty to Heidelberg Pharma will be delayed
Current cash reach until Q1 2026
Ladenbu [ … ]
Thu, 13.03.2025
Heidelberg Pharma AG
Ad hoc announcement - Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
HealthCare Royalty and Heidelberg Pharma amend royalty financing agreement to provide for USD 20 million payment
Heidelberg Pharma extends cash runway into 2027
Ladenburg, Ger [ … ]
